Tweenvest Stocks

Shanghai RAAS Blood Products Co., Ltd. (SZSE: 002252)

Health Care · Biotechnology · CN

CN¥4.82

-2.82% today · -31.6% 1Y

Shanghai RAAS Blood Products Co., Ltd. (SZSE: 002252) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.73B and employs 4,045 people.

Over the last twelve months the share price has lost 31.6%, trading between 4.18 and 7.26.

Tweenvest scores Shanghai RAAS Blood Products Co., Ltd. across four factors: quality 65/100, value 61/100, growth 44/100, dividend 14/100. Its strongest factor is quality.

002252 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$4.73B
Revenue (TTM)
$993.39M
P/E
23.82
EPS
0.20
Dividend yield
1.00%
Beta (5Y)
0.29
52-week high
CN¥7.26
52-week low
CN¥4.18
Avg volume (3M)
Shares outstanding
6.59B
Employees
4,045
Next earnings

About Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.

ISIN
CNE100000C31
Founded
1988
Listed since
Jun 23, 2008
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$264.96+1.20%
Amgen Inc.NasdaqGS: AMGN$237.52B$439.33+1.29%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$146.12+1.86%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$548.05+1.44%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$834.04+0.90%
argenx SEENXTBR: ARGX$65.85B902.00+1.90%
Moderna, Inc.NasdaqGS: MRNA$57.92B$145.13+0.04%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.